Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-023825
Filing Date
2020-05-11
Accepted
2020-05-11 06:31:51
Documents
80
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q prtk-10q_20200331.htm 10-Q 1645863
2 EX-10.1 prtk-ex101_348.htm EX-10.1 23694
3 EX-31.1 prtk-ex311_147.htm EX-31.1 18152
4 EX-31.2 prtk-ex312_9.htm EX-31.2 18312
5 EX-32.1 prtk-ex321_6.htm EX-32.1 6528
6 EX-32.2 prtk-ex322_8.htm EX-32.2 6421
  Complete submission text file 0001564590-20-023825.txt   7642396

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT prtk-20200331.xml EX-101.INS 1577371
8 XBRL TAXONOMY EXTENSION SCHEMA prtk-20200331.xsd EX-101.SCH 80469
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prtk-20200331_cal.xml EX-101.CAL 55711
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prtk-20200331_def.xml EX-101.DEF 251175
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE prtk-20200331_lab.xml EX-101.LAB 568763
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prtk-20200331_pre.xml EX-101.PRE 411964
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36066 | Film No.: 20862514
SIC: 2834 Pharmaceutical Preparations